Hello! Welcome back to the AGEs series. This is the second entry for the series. If you missed the first part, I encourage you to go back and read it before going through this second post. If you remember the previous entry, you most likely know about the main character, the Advanced Glycation End Product… Read More Decoding the Role of RAGE: Unveiling the Receptor for Advanced Glycation End Products
Pancreatic cancer is one of the deadliest forms of cancer, with a five-year survival rate of only 10%. This is largely because it is often diagnosed at a late stage, when treatment options are limited. However, a recent study published in Nature Medicine offers hope for improved survival rates through the use of a deep… Read More Can AI Outperform Radiologists in Early Pancreatic Cancer Detection?
Recently I came across a study in Nature Medicine that claimed to be able to use an artificial intelligence (AI) algorithm to predict the risk of pancreatic cancer. In order facilitate in the development of a surveillance program for early diagnosis, Placido et al. sought to predict the risk of pancreatic cancer from the clinical… Read More AI Predicting Pancreatic Cancer Risk for Early Detection
Arbona Health Hub 